![Mark Mossler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Mossler
Nessuna posizione attualmente
Patrimonio netto: 79 551 $ in data 31/05/2026
Profilo
Mark Mossler worked as Senior Director-Global Accounting at BeOne Medicines Ltd. from 2017 to 2023.
Mr. Mossler worked as Chief Accounting Officer at C4 Therapeutics, Inc. from 2023 to 2026.
Mr. Mossler completed undergraduate and MBA degrees at Babson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/02/2026 | 18.204 ( 0,02% ) | 79 551 $ | 31/05/2026 |
Precedenti posizioni note di Mark Mossler
| Società | Posizione | Fine |
|---|---|---|
| C4 THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15/05/2026 |
| BEIGENE LTD | Comptroller/Controller/Auditor | 01/06/2023 |
Formazione di Mark Mossler
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
